About: Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 April 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована у квітні 2011 (uk) artículu científicu espublizáu n'abril de 2011 (ast) scientific article published on 03 April 2011 (en) مقالة علمية نشرت في 03 أبريل 2011 (ar)
publication date	wds:Q37861366-61201C18-7FDB-4F66-AA65-5D4EA5156C26
publication date	2011-04-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37861366-6E97493E-77DB-4641-B054-F13CBE944551
language of work or name	English
cites work	wds:Q37861366-0E63BB13-66B5-479E-B0EA-8FE5377104C2 wds:Q37861366-0EB5AD8D-3163-4603-8F2E-C41B6243155B wds:Q37861366-185AEB9D-690A-4D3A-9A72-5C1BF783A1B3 wds:Q37861366-380C0786-D627-4AA1-BD0D-A275D88DCA2C wds:Q37861366-46ED52D0-17AC-4541-A9A8-A8BA3F71805B wds:Q37861366-47DCBCFF-D6F4-4737-B058-48FC3C0FA847 wds:Q37861366-4CA1C933-687B-40FE-858C-A8D657E089A0 wds:Q37861366-5799F524-1416-4295-BC2A-095AA3D54182 wds:Q37861366-596215BA-460F-408A-979B-BB2D41DB11E6 wds:Q37861366-85DEB8E3-3074-46B6-BDBA-98C2472F6752 wds:Q37861366-9368963E-8B11-4E5C-94B8-45FCF5A74291 wds:Q37861366-A09A6D6B-E131-494D-A6E7-186E09ECDE21 wds:Q37861366-A4AF3D17-D38E-4E2A-B54B-37E4EFC3ED78 wds:Q37861366-BFA229A3-FF9A-44ED-96D2-5B10810EBE24 wds:Q37861366-C054ECA8-5790-44FB-87EE-848B2AB3B94D wds:Q37861366-D460F3E0-BA95-4D99-9D1B-6DEE1EAD9210 wds:Q37861366-E452C33D-03EF-4035-814F-AE9729C580AB wds:Q37861366-F6D983C3-6147-4A6B-BAAE-7D1947476926
cites work	New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trial Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Clear-cell cancer of the ovary-is it chemosensitive? Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy Clinical characteristics of clear cell carcinoma of the ovary Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer
author name string	wds:Q37861366-3BE698C6-5916-4666-8C81-4B4397DB3BFE wds:Q37861366-70EA98E4-6393-4993-8F98-263E6177BB3B wds:Q37861366-8A3FFBB5-982A-4B0A-8A37-3FDAA3E13C3E wds:Q37861366-9AB22DD6-E362-4709-8409-D7FC07BA1AB6 wds:Q37861366-AF1C262A-3966-47AF-800A-911735D55EB2 wds:Q37861366-E0DC39E7-134E-4D36-B1DD-7564D53811AF
author name string	A Tinker J L Santos K D Swenerton H Lau P Hoskins J Al-Barrak
rdfs:label	Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (en) Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (nl)
skos:prefLabel	Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (en) Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (nl)
name	Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (en) Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (nl)
author	wds:Q37861366-38A0AB93-4E4E-4FA8-80D5-2B0DB1F13E7F
author	C. Blake Gilks
title	wds:Q37861366-E74A06EF-F694-4653-B9F4-E3931C251A7E
title	Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma (en)
page(s)	wds:Q37861366-C814BBD6-47CF-44EE-AD24-93EBC0A0F68A
page(s)	107-110
instance of	wds:Q37861366-F9C4D5AF-AF13-4627-B7E8-19EE919CFE26
instance of	scholarly article
PubMed ID	wds:Q37861366-1B474E90-6A77-4355-A4CC-FEE022EED2D8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21463887
PubMed ID	21463887
published in	wds:Q37861366-2D170B6D-794E-4F94-9D0D-5DFA76EDE43B
published in	Gynecologic Oncology
issue	wds:Q37861366-D4735C1A-8BB8-4EE6-8910-653B4BA0D879
volume	wds:Q37861366-212C64E4-DB20-44A4-95A1-44185FDC85D8
issue	1
volume	122
DOI	wds:Q37861366-EBB670DC-AF95-415B-9810-B785FDA01476
DOI	http://dx.doi.org/10.1016/J.YGYNO.2011.03.011
DOI	10.1016/J.YGYNO.2011.03.011
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37861366
is cites work of	Rethinking ovarian cancer: recommendations for improving outcomes Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software